Secora Michael
SEC insider (Form 3/4/5 filer). CIK 0001855980. CFO & Chief Corp Dev Ofcr at Iambic Therapeutics, Inc. (IAM) and 1 other issuer. 15 reported Form 4/5 transactions since Sep 2024; latest on Oct 16, 2026. Located in SAN DIEGO, CA.
Companies Secora Michael has filed insider reports for
- Iambic Therapeutics, Inc. (IAM): Officer, CFO & Chief Corp Dev Ofcr
- RECURSION PHARMACEUTICALS, INC. (RXRX): Officer, Chief Financial Officer
Secora Michael
CIK: 0001855980
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 16, 2026IAM
Iambic Therapeutics, Inc.
ConversionDirect61.3K shares- - Oct 14, 2026IAM
Iambic Therapeutics, Inc.
AwardDirect28.4K shares- - Nov 15, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
Tax PaymentDirect11.9K shares at avg. $6.17$74K - Nov 13, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect15K shares at avg. $7.66$115K - Nov 13, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
ExerciseDirect39.4K shares at avg. $2.22$87K - Nov 12, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
ExerciseDirect39.4K shares at avg. $2.22$87K - Nov 12, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect15K shares at avg. $7.64$115K - Oct 9, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
ExerciseDirect39.4K shares at avg. $2.22$87K - Oct 9, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
SaleDirect15K shares at avg. $6.36$95K - Oct 8, 2024RXRX
RECURSION PHARMACEUTICALS, INC.
ExerciseDirect39.4K shares at avg. $2.22$87K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 16, 2026 |  IAM Iambic Therapeutics, Inc. | Conversion | 61,342 | - | $0 | Direct |
| Oct 14, 2026 | IAM Iambic Therapeutics, Inc. | Award | 28,400 | - | $0 | Direct |
| Nov 15, 2024 |  RXRX RECURSION PHARMACEUTICALS, INC. | Tax Payment | 11,937 | $6.17 | $73,711 | Direct |
| Nov 13, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 15,000 | $7.66 | $114,876 | Direct |
| Nov 13, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | Exercise | 39,375 | $2.22 | $87,413 | Direct |
| Nov 12, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | Exercise | 39,375 | $2.22 | $87,413 | Direct |
| Nov 12, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 15,000 | $7.64 | $114,629 | Direct |
| Oct 9, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | Exercise | 39,375 | $2.22 | $87,413 | Direct |
| Oct 9, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | Sale | 15,000 | $6.36 | $95,375 | Direct |
| Oct 8, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | Exercise | 39,375 | $2.22 | $87,413 | Direct |
1-10 of 15 transactions